You are here: Industry Insights > drug prices

News List

Thank politicians—and maybe your doctor—as the drug price advertising debate drags on fiercepharma
December 25, 2018
Politicians on both sides of the aisle refuse to let go of the proposal to force pharma companies to add drug pricing to ads. But Washington insiders aren't solely to blame. Consumers and many physicians are quite keen on the idea, too.
FiercePharma's annual look ahead, when the past really does predict the future fiercepharma
December 24, 2018
In my files I have two sets of stapled pages listing every medication my parents took last year. They’re long lists. Blood pressure drugs, statins for cholesterol, painkillers.
After New Year's, expect more drug pricing fireworks in 2019 pharmatimes
December 24, 2018
For several years, pharma watchers have witnessed drug pricing grow into a top issue facing the industry, dominating discussion almost daily.
Thank politicians—and maybe your doctor—as the drug price advertising debate drags on fiercepharma
December 20, 2018
Politicians on both sides of the aisle refuse to let go of the proposal to force pharma companies to add drug pricing to ads. But Washington insiders aren't solely to blame. Consumers and many physicians are quite keen on the idea, too.
As competition heats up, U.S. prices for Remicade and biosims slip: analyst fiercepharma
December 12, 2018
As Johnson & Johnson vies with biosimilars to its big-selling Remicade, prices across the category are gradually falling, an analyst says—and Pfizer's Inflectra has taken the biggest tumble.
Johnson & Johnson chief figures Amazon could shake up pharma's distribution, rebates and more fiercepharma
December 12, 2018
There’s been plenty of speculation about Amazon's intentions in pharmaceuticals, and now Johnson & Johnson’s CEO has weighed in on how the tech giant could affect drug markets by shaking up pharma distribution and reimbursement.
Step off our 'doughnut hole' deal: AARP ads take on Big Pharma lobbying fiercepharma
December 10, 2018
AARP is taking on Big Pharma with a new campaign to convince lawmakers to resist drug industry lobbying. In new TV ads begun last week, the advocate for older Americans urges
Pharma caps U.K.’s branded-drug spend growth at 2% in exchange for faster drug launches fiercepharma
December 10, 2018
How much are pharma companies willing to pay in exchange for a faster trip to market in the U.K.? As it turns out, a cap of 2% on total branded-drug sales growth should do.
The top 3 House Democrat leaders have pocketed millions from pharma fiercepharma
December 06, 2018
Three of the lawmakers who will lead the House next year as Congress focuses on skyrocketing drug costs are among the biggest recipients of campaign contributions from the pharmaceutical industry, a new KHN analysis shows.
Taking aim at Medicaid misclassifications like Mylan's EpiPen, senators look to end a 'pharma ripoff' fiercepharma
December 06, 2018
Amid Mylan’s EpiPen pricing firestorm in 2016 and 2017, the company came under fire for misclassifying the lifesaving injector as a generic on Medicaid, allowing it to drastically underpay rebates.

Previous page 1 2 3 4 Next page